Cover Story
Meet Barbara Byrd Keenan, The Endocrine Society’s New CEO
In the wake of Scott Hunt’s retirement after a quarter century at the helm of The Endocrine Society, Barbara Byrd Keenan has been named the new CEO. Keenan was chosen after an exhaustive, months-...
Features
Staying THE COURSE
The evidence is clear: Not taking immune-suppressing meds as prescribed threatens transplanted kidneys. So why do so many patients stray?
